Development of Protease Inhibitors and the Fight with Drug‐Resistant HIV‐1 Variants
Author:
Publisher
Elsevier
Reference101 articles.
1. TMC114/ritonavir substitution for protease inhibitor(s) in a non‐suppressive antiretroviral regimen: A 14‐day proof‐of‐principle trial;Arasteh;AIDS,2005
2. In‐vitro tipranavir susceptibility of HIV‐1 isolates with reduced susceptibility to other protease inhibitors;Back;AIDS,2000
3. Toxicity of antiretroviral therapy and implications for drug development;Carr;Nat. Rev. Drug Discov.,2003
4. Non‐peptidic HIV protease inhibitors;Chrusciel;Curr. Top. Med. Chem.,2004
5. Flap opening in HIV‐1 protease simulated by ‘activated’ molecular dynamics;Collins;Nat. Struct. Biol.,1995
Cited by 52 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. In vitro selection and analysis of SARS-CoV-2 nirmatrelvir resistance mutations contributing to clinical virus resistance surveillance;Science Advances;2024-07-26
2. Benchmarking ANI potentials as a rescoring function and screening FDA drugs for SARS-CoV-2 Mpro;Journal of Computer-Aided Molecular Design;2024-03-27
3. Identification of SARS-CoV-2 Mpro inhibitors containing P1’ 4-fluorobenzothiazole moiety highly active against SARS-CoV-2;Nature Communications;2023-02-25
4. COVID-19 Therapeutics: Use, Mechanism of Action, and Toxicity (Xenobiotics);Journal of Medical Toxicology;2022-12-16
5. Fluorine Modifications Contribute to Potent Antiviral Activity against Highly Drug-Resistant HIV-1 and Favorable Blood-Brain Barrier Penetration Property of Novel Central Nervous System-Targeting HIV-1 Protease Inhibitors In Vitro;Antimicrobial Agents and Chemotherapy;2022-02-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3